In the last year, Swiss pharma giant Novartis has spent nearly $15 billion on acquisitions that are pivoting the company toward treatments that bear little resemblance to traditional drugs, according ...
Cardiovascular disease can be managed with drugs that take various approaches, but few of them work by reducing inflammation. Novartis is getting an anti-inflammatory drug candidate through its $1.4 ...
EVANSTON, Ill., Feb. 9, 2025 /PRNewswire/ -- Novartis took home the top spot in the 21 st Kellogg School Super Bowl Advertising Review with its "Your Attention, Please" ad putting a spotlight on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback